 |
 |
|||||
  |
 |
 |
 |
 |
 |
|
 |
|
Dan Quinn has nearly 20 years of communications experience with a strong emphasis on health care, corporate communications, and biotechnology. Dan joined Feinstein Kean Healthcare after nearly seven years at Genzyme Corporation, where he served most recently as director of corporate communications. At Genzyme, Dan worked to protect and enhance the company’s global reputation through financial, product, employee, and crisis communications initiatives, and worked closely with marketing teams throughout the company on the launch and positioning of several new therapies. Prior to joining Genzyme, Dan promoted the health policy research of the National Academy of Sciences’ Institute of Medicine, ensuring successful outreach to media, Congress, government agencies and advocacy interests. Dan has served in leadership communications roles at Resources for the Future, a non-partisan environmental research organization in Washington, DC, and at Tufts University School of Medicine. He began his career as a journalist at newspapers in Massachusetts after graduating from Providence College in Providence, R.I. |
|
||||
 |
||||||
|
|
|
|
|